Literature DB >> 20070420

Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality.

Cecilia Big1, Preeti N Malani.   

Abstract

OBJECTIVES: To assess clinical outcomes and identify risk factors for mortality in older adults with Staphylococcus aureus bloodstream infection (SAB).
DESIGN: Retrospective review.
SETTING: University of Michigan Health System, Ann Arbor. PARTICIPANTS: All patients aged 80 and older with SAB between January 2004 and July 2008. MEASUREMENTS: Clinical data, including comorbid conditions, SAB source, echocardiography results, Charlson Comorbidity Index, mortality (in-hospital and 6-month), and need for rehospitalization or chronic care after discharge.
RESULTS: Seventy-six patients aged 80 and older (mean 85.5 +/- 4.2) with SAB were identified. Infection sources included 14 (18.4%) vascular catheter associated, 16 (21.1%) wound related, seven (9.2%) endocarditis, five (6.6%) intravascular, and 19 (25%) with unknown source; 46 (60.5%) patients had methicillin-resistant strains. Twenty-two (28.9%) patients underwent surgery or device placement within 30 days of developing SAB; 10 of these 22 had SAB associated with surgical site infection (SSI). Twenty two (28.9%) patients died in the hospital or were discharged to hospice care; at least 43 (56.6%) patients died within 6 months of presentation, and eight were lost to follow-up. Unknown source of bacteremia (odds ratio=5.2, P=.008) was independently associated with in-hospital death. Echocardiography was not pursued in 45% of patients. Of surviving patients, 40 (74.1%) required skilled care after discharge; eight (20%) required rehospitalization.
CONCLUSION: SAB was associated with high mortality rates in patients aged 80 and older. The observed association between SAB and SSI may direct preventive strategies such as perioperative decolonization or antimicrobial prophylaxis. Interventions to optimize clinical care practices in elderly patients with SAB are essential given the associated morbidity and mortality.

Entities:  

Mesh:

Year:  2010        PMID: 20070420     DOI: 10.1111/j.1532-5415.2009.02666.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  16 in total

Review 1.  Colonization, pathogenicity, host susceptibility, and therapeutics for Staphylococcus aureus: what is the clinical relevance?

Authors:  Steven Y C Tong; Luke F Chen; Vance G Fowler
Journal:  Semin Immunopathol       Date:  2011-12-11       Impact factor: 9.623

2.  Screening cardiac surgery patients for MRSA: an economic computer model.

Authors:  Bruce Y Lee; Ann E Wiringa; Rachel R Bailey; Vishal Goyal; G Jonathan Lewis; Becky Y K Tsui; Kenneth J Smith; Robert R Muder
Journal:  Am J Manag Care       Date:  2010-07-01       Impact factor: 2.229

Review 3.  Bloodstream infections in older patients.

Authors:  Dafna Yahav; Noa Eliakim-Raz; Leonard Leibovici; Mical Paul
Journal:  Virulence       Date:  2015-12-18       Impact factor: 5.882

4.  A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Sarah C J Jorgensen; Abdalhamid M Lagnf; Sahil Bhatia; Michael J Rybak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-02-08       Impact factor: 3.267

Review 5.  Bloodstream infections in the elderly: what is the real goal?

Authors:  Yaara Leibovici-Weissman; Noam Tau; Dafna Yahav
Journal:  Aging Clin Exp Res       Date:  2019-09-05       Impact factor: 3.636

6.  Thrombocytopenia in Staphylococcus aureus bacteremia: risk factors and prognostic importance.

Authors:  Anat Gafter-Gvili; Nariman Mansur; Assaf Bivas; Noa Zemer-Wassercug; Jihad Bishara; Leonard Leibovici; Mical Paul
Journal:  Mayo Clin Proc       Date:  2011-05       Impact factor: 7.616

Review 7.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Outcome of methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia: impact of diabetes.

Authors:  Anne Vanderschelden; Christophe Lelubre; Thibault Richard; Salah Eddine Lali; Soraya Cherifi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-05       Impact factor: 3.267

9.  Bayesian model averaging: improved variable selection for matched case-control studies.

Authors:  Yi Mu; Isaac See; Jonathan R Edwards
Journal:  Epidemiol Biostat Public Health       Date:  2019

10.  Visualization of interaction between inorganic nanoparticles and bacteria or fungi.

Authors:  André Chwalibog; Ewa Sawosz; Anna Hotowy; Jacek Szeliga; Stanislaw Mitura; Katarzyna Mitura; Marta Grodzik; Piotr Orlowski; Aleksandra Sokolowska
Journal:  Int J Nanomedicine       Date:  2010-12-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.